T2 Biosystems Receives $10,800,000 Series B Round
-
Feed Type
-
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=b1fbb0aa-8310-4569-a11c-9ee157320d1f&Preview=1 -
Date
10/17/2008 -
Company Name
T2 Biosystems -
Mailing Address
286 Cardinal Medeiros Avenue Cambridge, MA 02141 -
Company Description
T2 Biosystems is a newly formed diagnostics company ushering in a new wave of innovative products to improve medical decision-making and treatment. Our proprietary biosensor technology was invented by a team of world-renowned scientists at MIT and Massachusetts General Hospital. Using this technology, we are developing a range of diagnostic products to impact a variety of health care settings; from centralized testing laboratories to point of care. -
Website
http://www.t2biosystems.com
-
Transaction Type
Venture Equity -
Transaction Amount
$10,800,000 -
Transaction Round
Series B -
Proceeds Purposes
Proceeds from the financing will be used to accelerate the development of T2 Biosystems’ revolutionary rapid diagnostic platform. -
M&A Terms
-
Venture Investor
In-Q-Tel -
Venture Investor
Flagship Ventures -
Venture Investor
Polaris Venture Partners -
Venture Investor
Flybridge Capital Partners
